24+ year AI Enterprise Leader building and scaling Data & AI Practices for global Life Sciences enterprises. Trusted Transformation Advisor to C-suites across Top 3 & Top 5 Global Pharma, Diagnostics Leaders, and Consumer Health Giants.
Combining deep Life Sciences domain mastery, board-level strategic AI framing, and a proven track record of winning against Big 4 consulting competitors.
24+ year AI enterprise leader building and scaling Data and AI Practices for global Life Sciences enterprises. Currently leading the Data & AI Practice at Infosys Consulting (Life Sciences & MedTech).
Deep expertise across Agentic AI & AI Agents, Responsible AI Governance, Gen AI Industrialization and Enterprise Data for AI — with a proven track record of winning marquee AI enterprise mandates against Big 4 competitors, shaping AI transformation roadmaps at CDO/CTO/CEO level, and deepening CXO relationships into multi-year AI partnerships.
Trusted AI Transformation Advisor to C-suite at Top 3 Global Pharma, Top 5 Global Pharma, Top Innovative Pharma, Top 5 Pharma & Diagnostics, and Global Consumer Healthcare Leaders.
| Metric | FY23/24 | FY24/25 | FY25/26 |
|---|---|---|---|
| Sales Credit | $2.5M | $4.0M | $6.0M |
| Managed Credit | $2.0M | $3.6M | $5.4M+ |
| Headcount Growth | +50% YoY | +60% YoY | +65% YoY |
High-impact leadership milestones across multi-million dollar practice scaling, board-level CEO presentations, and enterprise RFP wins against Big 4 consulting firms.
Scaled Sales Credit from $2.5M → $4.0M → $6.0M across FY23/24–FY25/26 with headcount growth +50% → +60% → +65% YoY at 83% consistent utilization. Owned P&L-equivalent metrics governing $6M+ in billable revenue.
Partnered with Articulus to architect and present the Infosys 10-Year Life Sciences Partnership Value Proposition directly to the client CEO for a Board-level strategic deal.
25% competed head-to-head against incumbent Big 4 consulting firms. Win rate across marquee enterprise AI & Gen AI transformation programmes defining high-growth multi-year mandates.
Won competitive enterprise mandates for Agentic AI & AI Agent programmes — PSP Agents (Top 3 Global Pharma), TPRM AI Reimagination and Sales Rep AI Reimagination — defining AI transformation roadmaps.
Recognized for practice growth, sustained CSAT 7/7 delivery and AI offering leadership across FY23–FY26 spanning 13+ Life Sciences clients globally.
Delivery Excellence recognition for sustained program management and measurable client value realization in AI & Data transformation programs.
Built, led, packaged into Go-To-Market offerings, and client-validated across Top 3–10 Global Pharma, MedTech, and Biotechnology enterprises.
Agentic Governance Navigator; Board & Audit Committee Dashboard; Dark AI detection; Control monitoring across 8 risk dimensions.
Swiss Eye Care MedTech AI Control Tower; 14 mock PV scenarios, 22-point risk classification, and automated compliance auditing.
UK Consumer Health & Swiss Pharma Pioneer third-party risk management (TPRM) reimagination with automated RAI compliance gates.
3-pillar AI cost governance; CFO/COO/CTO calculator; token consumption/revenue baseline; 30–40% AI spend reduction.
Swiss Pharma Sales Rep AI RFP win + NOVA OS Field Orchestration; pre-call HCP Avatar simulation; FMR/PSP coaching; post-call automation.
US Pharma Giant PSP — 5 AI Agents; patient assistance & adherence; 40% coordination cost reduction; 24/7 autonomous support journey.
AI-powered Mixed Media Modelling — ROI attribution across HCP field, digital & events; HCP engagement & incentive optimization.
AI HCP targeting & next-best-action agents; payer analytics; formulary positioning; incentive intelligence.
GenAI + Agentic AI for CHC regulatory dossiers; evidence retrieval; citation validation; GenAI + 21 CFR Part 11 compliant authoring.
Real-time AI signal detection + OMOP CDM for RWD/RWE analytics; UK-Sweden Biopharma PV safety AI platform.
Clinical trial dashboards + regulatory submission AI + FDA/SMO lifecycle automation; eCTD / RIM support.
Gen AI UCI + Swiss Pharma Pioneer GAIN Platform + Swiss Diagnostics Leader (Roche) AI factory industrialization.
300+ measures live, 40% discovery cycle compression, 30% AI query accuracy gain for Swiss Pharma Pioneer.
3 domain CDMs, Quality/SCM, Packaging, Legal Ops; AI-ready CDM/PDM metadata management for UK Consumer Health Co.
6 AI programmes chained: PSP → PGS → SCM Agents → HSE. Awarded enterprise AI data engineering pipelines for US Pharma Giant.
OMOP CDM, feature stores, LLM data pipelines & RAG knowledge graphs for AI training and decision support.
17+ Global Life Sciences & MedTech clients — advancing from single initial engagements to enterprise-scale, multi-year AI transformation partnerships.
Delivered AI Governance and AI Democratization initiatives across Clinical, Quality, Safety, and Regulatory functions, leveraging Veeva Vault, Quick RAG, Marketing Mix Modelling, Sustainability AI, and Marketing Data Foundations. Successfully led 10 AI programmes over 3 years, spanning the full AI lifecycle from strategy and governance to implementation and scale.
Delivered PSP Commercial AI, CORA AI for R&D Regulatory, PGS Data Governance, PGS Supply Chain AI Agents, Manufacturing HSE AI Agents, and Data Engineering Pipelines, while scaling AI Developers, SMEs, and Product Managers across Commercial, R&D, Supply Chain, and Manufacturing functions. Each AI programme added AI Developers, Specialists & Product Managers — full AI continuum across Commercial, R&D, Supply Chain & Manufacturing.
Enterprise Data Management across 14 domains, centralized EDM operations, Patient Safety MDM transformation, Sales Rep AI reimagination, NovaOS Field Orchestration, Data and analytics platform, Semantic layer for AI, Veeva-to-Salesforce agent migration, PSP deployment across markets, AI-driven GRC and procurement modernization, and scalable AI specialists supporting every growth phase.
Enterprise Multi-Client: AIGaaS Platform with 14+ use cases, EU AI Act & ISO 42001 readiness. Swiss Pharma: AI Control Tower, 14 mock PV, 22-point risk model, RAI Revamp & TPRM AI Reimagination.
Swiss Pharma: Sales Rep AI RFP Win & Nova OS (40% cost reduction). US Pharma: PSP Agentic AI (5 agents, 40% cost reduction, 24/7 care). California Biopharma: AI Literacy as a Service.
Paris CHC (Opella): AI Medical Writing (Module 2.5 & 2.7, 24% cycle reduction, GenAI + 21 CFR Part 11, 12-week pilot). Swiss Pharma: GAIN Platform AI Certification (50+ Gen AI use cases, EU AI Act risk tiers).
UK-Sweden Biopharma: PV Safety & OMOP CDM implementation — 2–4 weeks earlier safety signal detection and 6–8 week accreditation acceleration.
Swiss Pharma: Semantic Layer & DAP on Snowflake Cortex (30% AI query accuracy gain). UK Consumer Health: SQLDBM Canonical Data Model (3 domain CDM, Quality/SCM, Packaging).
US Pharma Giant: AI Data Engineering Programme — accelerated enterprise AI programs delivery, scaling data engineering capabilities across Commercial, R&D, Supply Chain & Manufacturing.
A rare convergence of Life Sciences domain depth, enterprise AI deal-making, CXO advisory, and $6M+ practice leadership — directly aligned to EY's growth mandate.
Leads every client engagement as an AI Transformation Partner — opens with regulatory exposure & cost-of-inaction framing, defines AI strategy and roadmap aligned to client business objectives, and closes with a phased 90-day path. Built to win enterprise AI deals, build CXO pipelines, and enable EY sales at scale in Life Sciences.
Won and led enterprise AI mandates at Top 3, Top 5 & Global CHC Pharma against Big 4 incumbents — shaping AI strategy at CDO/CTO/CEO level and converting CXO relationships into multi-year AI transformation partnerships. Fluent in GenAI architecture (LangGraph, AutoGen, CrewAI) and boardroom AI risk & ethics language.
$6M+ practice, 17+ global LS & MedTech clients across Top 3, Top 5, Top 10 Global Pharma, Global CHC, Specialty Pharma, MedTech & Biopharmaceutical — 7/7 CSAT sustained across multi-year engagements. Immediate day-one Associate Partner contribution across business development, engagement leadership and capability build.
Responsible AI as a Service • AIGaaS • AI Security as a Service • AI Literacy • AI FinOps • AI Semantic Layer • Agentic AI Reimagination — all GTM-packaged & client-delivered. Oversees ethical AI practices (fairness, accountability & transparency). Manages risk & compliance with EU AI Act, FDA, ISO 42001 standards.
Bridges clinical, commercial, regulatory, PV & data domains with hands-on AI strategy leadership. Identifies business needs, defines AI roadmaps, designs end-to-end AI solutions (process + people + data + technology) and leads multifunctional teams — speaking CDO, CTO, CMO, COO and CFO in the same room. Solutionizes live into a 3-layer transformation roadmap.
Infosys Annual Excellence Award Nominee • AIM Prestigious Award from CMO & CIO • 83% consistent utilization • 7/7 CSAT across FY23–FY26 spanning 13+ Life Sciences clients globally. 24+ years of delivery excellence with competitive RFP wins and measurable client value realization in Life Sciences AI & Data programs.